1 min read

Chemical Science Scotland
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

Research Triangle Park, N.C., USA, 13th August 2019 / AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression. Synpromics will operate as a wholly owned subsidiary and remain headquartered in Edinburgh, United Kingdom.

Click here to read more.

For more information please follow links below.

Scotsman

Herald

Labiotech

End Point News

Wral Tech Wire

The Times

Pharmiweb